Photo de couverture de EDAP TMS
EDAP TMS

EDAP TMS

Fabrication d’équipements médicaux

Vaulx-en-Velin, Auvergne-Rhône-Alpes 6 725 abonnés

Bringing New Horizons to Therapy

À propos

EDAP TMS is a high-tech medical company listed on the Nasdaq (EDAP) which develops, manufactures and markets minimally invasive medical devices using ultrasound technology for various medical applications and offers a wide portfolio of complementary distribution products in urology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in 2013 in Europe and in 2018 in the US as the answer to all requirements for ideal prostate tissue ablation as a complement to the existing FDA-cleared Ablatherm® Robotic HIFU and Ablatherm® Fusion. As a pioneer and key player in the field of extracorporeal shock wave lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems. EDAP TMS is listed on NASDAQ market in New York under ticker symbol “EDAP”.

Secteur
Fabrication d’équipements médicaux
Taille de l’entreprise
201-500 employés
Siège social
Vaulx-en-Velin, Auvergne-Rhône-Alpes
Type
Société cotée en bourse
Fondée en
1979
Domaines
Medical Device, Prostate Cancer, HIFU, ESWL, Urology, Therapeutic Ultrasound, Urinary stones, Research & Development et Endometriosis

Lieux

Employés chez EDAP TMS

Nouvelles

  • EDAP TMS a republié ceci

    Voir la Page de l’organisation de Focal One

    4 200  abonnés

    World’s First Remote Transatlantic Focal One Robotic HIFU Focal Therapy Procedure for Prostate Cancer was successfully performed between Cleveland Clinic, Ohio in the United States and Cleveland Clinic Abu Dhabi in the United Arab Emirates, two hospitals that are separated by over 11,400 km (7,000 miles).    The patient was treated at Cleveland Clinic Abu Dhabi by Waleed Hassen MD, MBA, urologic surgeon. Dr. Ruben Olivares, urologic surgeon from Cleveland Clinic Ohio, connected remotely to the Focal One system in Abu Dhabi through an EDAP-developed proprietary workstation and directly controlled the Focal One system in real-time to perform the procedure.   Congratulations to the Cleveland Clinic and Focal One teams on this historic milestone in the evolution of Robotic Focal HIFU in conducting the first ever successful Focal One remote procedure in the management of prostate cancer!   #Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #Healthcare | #Medicine

    Voir la Page de l’organisation de Cleveland Clinic Abu Dhabi

    460 427  abonnés

    Our experts from Cleveland Clinic Abu Dhabi and Cleveland Clinic U.S. share insights into the groundbreaking, world-first transcontinental robotic-assisted focal therapy procedure for prostate cancer. This innovative remote procedure demonstrates the transformative potential of advanced technology in expanding access to specialized care. We are proud to continue setting new standards in healthcare and further strengthening the UAE’s position as a global leader in the field.

  • Voir la Page de l’organisation de EDAP TMS

    6 725  abonnés

    We are proud to join in highlighting the successful completion of the world’s first transcontinental robotic-assisted focal therapy procedure for prostate cancer—connecting experts across 11,000 km between Cleveland Clinic Abu Dhabi and Cleveland Clinic in Ohio. This milestone, operated by Dr Waleed Hassen MD, MBA & Dr. Ruben Olivares, showcases the power of advanced medical technology to push the boundaries of what's possible in patient care—bringing together precision, expertise, and real-time global coordination. A true testament to what can be achieved when vision meets innovation. Congratulations to all the teams involved in making history #Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #Healthcare | #Medicine

    Voir la Page de l’organisation de Cleveland Clinic Abu Dhabi

    460 427  abonnés

    Our experts from Cleveland Clinic Abu Dhabi and Cleveland Clinic U.S. share insights into the groundbreaking, world-first transcontinental robotic-assisted focal therapy procedure for prostate cancer. This innovative remote procedure demonstrates the transformative potential of advanced technology in expanding access to specialized care. We are proud to continue setting new standards in healthcare and further strengthening the UAE’s position as a global leader in the field.

  • Voir la Page de l’organisation de EDAP TMS

    6 725  abonnés

    We were proud to be part of the Imperial Prostate & Focal Therapy Society Masterclass, where the future of prostate cancer care was on full display, from cutting-edge focal therapy options to the growing role of genomic profiling, all with one clear focus: putting the patient at the centre of every decision. A special thank you to Prof. Giovanni Lughezzani for leading two “Meet the Expert” sessions, bringing together over 30 surgeons passionate about innovation in prostate cancer management with Robotic HIFU. The discussions highlighted the clinical value, advantages, safety, and ergonomics of Robotic HIFU. Laure Bonnemaison, Pierre Rivery, and —— Damien Desmedt —— were pleased to connect with international leaders and exchange on the evolving landscape of prostate care. Michel Azzarello had the opportunity to demonstrate the system showcasing its value in the clinical pathway. Maud Declomesnil, Application Engineer for #ExactVu & the JAMA 2025 OPTIMUM publication, were met with great enthusiasm this year — an exciting milestone for Exact Imaging and the Micro Ultrasound technology. We leave IPM 2025 inspired, and more committed than ever to advancing prostate cancer care. #Cancer #ProstateCancer #Urology #RoboticSurgery #MedTech #ipftsmasterclass25 Focal One

    • Aucune description alternative pour cette image
  • EDAP TMS a republié ceci

    Voir le profil de Giovanni Lughezzani

    Associate Professor of Urology

    Grateful to have taken part in the Imperial Prostate & Focal Therapy Society Masterclass 2025 at Imperial College London, an exceptional event focused on the future of focal therapy in prostate cancer. I had the opportunity to lead two hands-on workshops on the use of HIFU with Focal One, discussing its role in precision treatment strategies and engaging with a truly international group of experts and colleagues. Huge thanks to the organizers and all participants for the insightful conversations and great energy throughout the event. Exciting times ahead in prostate cancer innovation! #FocalTherapy #ProstateCancer #HIFU #FocalOne #UrologyInnovation #ImperialCollege #FocalTherapySociety

    • Aucune description alternative pour cette image
    • Aucune description alternative pour cette image
    • Aucune description alternative pour cette image
  • Voir la Page de l’organisation de EDAP TMS

    6 725  abonnés

    Focal One at the forefront of innovation at the Imperial Prostate Masterclass 2025   We are proud to announce that Focal One will be attending the Imperial Prostate & Focal Therapy Society Masterclass in London, April 11–12 ; a leading event focused on minimally invasive surgery and focal therapy in prostate cancer. On this occasion, we are honored to sponsor two hands-on workshops led by Professor Giovanni Lughezzani. These exclusive sessions will give participants the opportunity to explore patient selection criteria, deepen their knowledge of clinical best practices, discuss focal treatment strategies 📍Join us for the hands-on sessions https://lnkd.in/gVxzrukR 📅 Date: Saturday, April 12 🕥 Time: 10:15–11:00 & 11:00–11:45   A unique opportunity to work directly with cutting-edge technology, gain practical skills, and exchange with experts on the evolving landscape of focal therapy for prostate cancer. We’ll also be available throughout the event — feel free to stop by and learn more about Focal One & ExactVU technologies   #Cancer  #ProstateCancer  #Urology  #RoboticSurgery  #MedTech #ipftsmasterclass25 Exact Imaging

  • EDAP TMS a republié ceci

    Voir la Page de l’organisation de Focal One

    4 200  abonnés

    As #EndometriosisAwarenessMonth comes to an end, we're proud to announce that Focal One Robotic HIFU just received CE marking for the treatment of deep posterior endometriosis infiltrating the rectum. Endometriosis is a chronic disease that affects 1 in 10 women of reproductive age. Patient health is at the heart of what we do, and we’re looking forward to the opportunity of helping women suffering from this debilitating condition. #MedTech | #RoboticSurgery | #Endometriosis | #WomensHealth

    • Aucune description alternative pour cette image
  • Voir la Page de l’organisation de EDAP TMS

    6 725  abonnés

    🎗️ Aujourd'hui, c'est la Journée Mondiale de Lutte contre l'Endométriose🎗️ L'Endométriose est une maladie chronique qui touche 1 femme sur 10 en âge de procréer, impactant le quotidien des femmes à toutes les étapes de leur vie, mais trop souvent invisibilisée.    Les annonces du Ministère de la Santé français, concernant les initiatives de sensibilisation, de formation et de mise en place de centres-experts, sont une étape supplémentaire pour accélérer le diagnostic de l'Endométriose et l'accès aux solutions thérapeutiques.    En cette Journée Mondiale de Lutte contre l'Endométriose, nous annonçons que le système robotisé Focal One HIFU vient de recevoir le marquage CE pour le traitement de l'endométriose profonde postérieure, infiltrant le rectum. Ceci intervient en même temps que notre transition MDR. L'amélioration de la santé des femmes en apportant une alternative thérapeutique est au cœur de notre mission. Nous sommes fiers d’apporter des solutions concrètes aux patientes et aux professionnels de santé. Merci à toutes les équipes impliquées dans ce projet. #Endométriose #SantéDesFemmes #InnovationMédicale #CEmark #FocalOne

    • Aucune description alternative pour cette image
  • Voir la Page de l’organisation de EDAP TMS

    6 725  abonnés

    Voir la Page de l’organisation de European Association of Urology

    18 640  abonnés

    🔥 BREAKING: Our #EAU25 game changers are here! As EAU25 fast approaches, we are happy to announce the latest ground-breaking studies that will be presented in Madrid. 📅 21 - 24 March, 10:00 - 10:30 CET 🔹Friday (Urothelial Cancer) • Perioperative outcomes of neoadj TAR-200 plus CET or CET alone in pts with MIBC ineligible for or NAC • NIAGARA 🔹 Saturday (OAB & LUTS) • FUTURE • WATER III 🔹 Sunday (Prostate Cancer | Urolithiasis) • TRANSLATE • OPTIMUM • APPEAL • RAMPP 🔹 Monday (Prostate Cancer) • NeuroSAFE PROOF • AURORAX-0087A • ARANOTE • SPCG-13 trial (Final 10-yr survival results) Visit https://lnkd.in/erbMTwcQ to check the abstracts and presenters of the game changers! 🔎Search for ‘game changers’ to view each day’s session. See you in Madrid!

    • Aucune description alternative pour cette image

Pages similaires

Parcourir les offres d’emploi